Addiction, Author Interviews, JAMA, Opiods, Pediatrics / 10.09.2018
Adolescents Face Large Addiction-Treatment Gap
MedicalResearch.com Interview with:
[caption id="attachment_44348" align="alignleft" width="200"]
Dr. Hadland[/caption]
Scott E. Hadland, MD, MPH, MS
Assistant Professor of Pediatrics
Boston Medical Center / Boston University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Amidst a worsening overdose epidemic in the United States, adolescents and young adults have not been spared. Although evidence-based medications like buprenorphine, naltrexone, and methadone are recommended for adolescents and young adults, the extent to which youth receive these medications — and whether these medications help retain youth in addiction treatment — isn’t yet known.
Dr. Hadland[/caption]
Scott E. Hadland, MD, MPH, MS
Assistant Professor of Pediatrics
Boston Medical Center / Boston University School of Medicine
MedicalResearch.com: What is the background for this study?
Response: Amidst a worsening overdose epidemic in the United States, adolescents and young adults have not been spared. Although evidence-based medications like buprenorphine, naltrexone, and methadone are recommended for adolescents and young adults, the extent to which youth receive these medications — and whether these medications help retain youth in addiction treatment — isn’t yet known.
